161 related articles for article (PubMed ID: 11769084)
1. [Fundamental bases of urothelial carcinogenesis].
Chopin D; Cappellen D; Fradvanyi F; Gattegno B
Prog Urol; 2001 Nov; 11(5):879-924. PubMed ID: 11769084
[No Abstract] [Full Text] [Related]
2. The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging.
Painter DJ; Timoney AG; Denton K; Alken P; Keeley FX
BJU Int; 2007 May; 99(5):973-7. PubMed ID: 17437428
[No Abstract] [Full Text] [Related]
3. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
4. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.
Sung MT; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Wang M; Tan PH; Cheng L
Clin Cancer Res; 2008 Apr; 14(7):1947-55. PubMed ID: 18381932
[TBL] [Abstract][Full Text] [Related]
5. [Carcinogenic pathways and natural history of upper tract urothelial carcinomas: state-of-the-art review for the yearly scientific report of the French National Association of Urology].
Seisen T; Cancel-Tassin G; Colin P; Cussenot O; Rouprêt M
Prog Urol; 2014 Nov; 24(15):943-53. PubMed ID: 25158326
[TBL] [Abstract][Full Text] [Related]
6. Erdafitinib for advanced urothelial carcinoma.
Burki TK
Lancet Oncol; 2019 Sep; 20(9):e469. PubMed ID: 31378458
[No Abstract] [Full Text] [Related]
7. Molecular Pathology of Urothelial Carcinoma.
Al-Ahmadie H; Netto GJ
Clin Lab Med; 2024 Jun; 44(2):181-198. PubMed ID: 38821640
[TBL] [Abstract][Full Text] [Related]
8. Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability.
Hartmann A; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Blaszyk H
Hum Pathol; 2003 Mar; 34(3):222-7. PubMed ID: 12673555
[TBL] [Abstract][Full Text] [Related]
9. [Urothelial carcinomas of the upper tract: the myth became a reality].
Rouprêt M; Colin P
Prog Urol; 2014 Nov; 24(15):939-42. PubMed ID: 25195030
[No Abstract] [Full Text] [Related]
10. Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 Mutation.
Ali SM; Miller VA; Ross JS; Pal SK
Eur Urol; 2015 Jun; 67(6):1195-1196. PubMed ID: 25630452
[No Abstract] [Full Text] [Related]
11. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
12. Micropapillary urothelial carcinoma of the urinary tract.
Humphrey PA
J Urol; 2011 Sep; 186(3):1071-2. PubMed ID: 21784465
[No Abstract] [Full Text] [Related]
13. Significant Association of Cyclo-oxygenase 2 Genotypes with Upper Tract Urothelial Cancer.
Chang WS; Liao CH; Hsu CM; Huang CY; Fang HY; Kao PY; Tsai CW; Wu HC; Hu PS; Wang TC; Syu YR; Shui HA; Bau DT
Anticancer Res; 2015 May; 35(5):2725-30. PubMed ID: 25964551
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mouse urothelial cell lines in different phases of transitional-cell carcinogenesis.
De Boer WI; Rebel JM; Foekens JA; Vermey M; Van der Kwast TH
Int J Cancer; 1993 Jul; 54(6):1022-7. PubMed ID: 7687588
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC
J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461
[TBL] [Abstract][Full Text] [Related]
16. Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated cells from patients with urothelial carcinoma.
Inoue T; Sato K; Tsuchiya N; Matsuura S; Iinuma M; Habuchi T; Kato T
Urology; 2004 Sep; 64(3):617-21. PubMed ID: 15351620
[TBL] [Abstract][Full Text] [Related]
17. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
Mongiat-Artus P
Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
[No Abstract] [Full Text] [Related]
18. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
19. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T
Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637
[TBL] [Abstract][Full Text] [Related]
20. Biology of urothelial tumorigenesis: insights from genetically engineered mice.
Wu XR
Cancer Metastasis Rev; 2009 Dec; 28(3-4):281-90. PubMed ID: 20012171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
